Medical device design and manufacturing company, ITL Group, is returning to Medica in Düsseldorf with the message – ‘your future rests with us’.
Compamed
ITL is celebrating 40 years in the medical and diagnostics sector this year. The company’s portfolio includes in-vitro diagnostics (IVD), point-of-care devices, cancer staging and treatment, surgical robots and DNA sequencing.
ITL Group is returning to the medical technology event to showcase and discuss how its engineers are adapting existing and new technologies to develop diagnostics devices.
Visitors to ITL’s stand will be able to interact with the Lumipod demonstrator which hosts a range of IVD possibilities and applications in one device.
The device employs technologies such as near-field communication (NFC), wireless charging, an associated app and Bluetooth data transmission. Visitors can see what technology is currently possible and will be invited to discuss where the industry is heading.
Greg Smith, ITL Group’s business director, will be leading the team attending Medica 2017.
He said: “We’re delighted to be back at Medica in our 40th year and to share with old and new partners how ITL Group is continuing to push back the boundaries of what is possible for the medical technology sector – existing and future.
“We had a great reaction to our Lumipod project, last year, providing a real opportunity to start a conversation about innovation as well as showing some of the technologies our engineers are working on right now.
“Technology doesn’t stand still and we’ve looking forward to showing off Mark II with the aim of encouraging people to question how they could use the technologies in their future medical devices.”
ITL will be on Stand H20, in Hall 3 at Medica 2017. As well as demonstrating and discussing the Lumipod the team will be available to discuss new projects, staging competitions and giving visitors a chance to win free Kentish beer.